Although the results were early, Rafael Fonseca, MD, professor of medicine at the Mayo Clinic in Scottsdale, Ariz. told MedPage Today he was impressed.
-
Although the results were early, Rafael Fonseca, MD, professor of medicine at the Mayo Clinic in Scottsdale, Ariz. told MedPage Today he was impressed.
"The daratumumab data were the most exciting information presented at that session. The responses we saw in reduction of M-protein were impressive. I don't think you can get those kinds of reductions just with steroids. There was a dose response to the treatment as well. This drug has a lot of promise."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind